Related Experiment Video

Updated: Oct 17, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Examining the contribution of infant walkers to childhood poisoning

L S Mroz1, E P Krenzelok

  • 1Pittsburgh Poison Center, Children's Hospital of Pittsburgh, PA 15213, USA.

Veterinary and Human Toxicology
|February 12, 2000
PubMed

Insights

Baby walkers, while often associated with trauma, contribute less to infant poisonings than expected. However, young children in walkers are still exposed to household toxins, necessitating awareness of poisoning risks.

Area of Science:

  • Pediatrics
  • Toxicology
  • Consumer Product Safety

Background:

  • Baby walkers are commonly used for infants aged 5-15 months.
  • Despite awareness campaigns, walker-related accidents increased by 45% between 1986 and 1991.
  • The study investigated the role of baby walkers in pediatric poisonings.

Purpose of the Study:

  • To determine if baby walkers are a significant factor in childhood poisonings.
  • To identify the most common toxins involved in walker-related exposures.
  • To assess the severity of poisonings in infants using baby walkers.

Main Methods:

  • A 14-month prospective study was conducted at a regional poison information center.
  • Data was collected on pediatric poisoning exposures in children aged 5-15 months who were in baby walkers.
  • The prevalence and types of substances involved were analyzed.

Main Results:

  • 2.8% of 7,058 poisoning exposures occurred while the child was in a baby walker.
  • The mean age of affected children was 8.25 months, with 96% under 12 months.
  • Commonly involved substances included plants (56.7%), cleaning products (9.9%), and cosmetics (5.5%).
  • The majority (95%) of children were asymptomatic.

Conclusions:

  • Infant walkers contribute less to pediatric poisonings than anticipated.
  • Vulnerable infants in walkers are exposed to accessible household poisons.
  • Baby walker safety recommendations should include poisoning risks beyond trauma.

More Related Videos

Quantifying Learning in Young Infants: Tracking Leg Actions During a Discovery-learning Task11:18

Quantifying Learning in Young Infants: Tracking Leg Actions During a Discovery-learning Task

Published on: June 1, 2015

Related Concept Videos

Locomotion During Infancy and Toddlerhood01:29

Locomotion During Infancy and Toddlerhood

Children develop a wide range of gross motor skills during the first three years, as increasing muscle strength, balance, coordination, and nervous system maturation allow greater control over body movements. Development generally progresses from basic postural control to independent movement and later to activities such as jumping, climbing, and pedaling.Motor Development During the First YearMost infants begin rolling during the first several months, although the timing and direction can vary.
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...